NCT00007969View on ClinicalTrials.gov

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

Detox-B adjuvant

DRUG

verteporfin

Trial Locations (6)

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

33180

Mount Sinai Comprehensive Cancer Center at Aventura, Aventura

63131

Missouri Baptist Cancer Center, St Louis

80010

University of Colorado Cancer Center, Denver

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

15213-3489

University of Pittsburgh Cancer Institute, Pittsburgh

All Listed Sponsors
lead

QLT Inc.

INDUSTRY

NCT00007969 - Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter